Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

B-type Natriuretic Peptide Affects the Initial Response to Intravenous Glucose in a Placebo-controlled Cross-over Study in Healthy Volunteers

NCT01324739 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT01324739
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01324739 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
B-type Natriuretic Peptide Affects the Initial Response to Intravenous Glucose in a Placebo-controlled Cross-over Study in Healthy Volunteers
Lead sponsor
Medical University of Vienna
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2010
Completion date
October 31, 2010
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiomyopathy, diabetes mellitus